Literature DB >> 16709649

Contractile properties of EDL and soleus muscles of myostatin-deficient mice.

Christopher L Mendias1, James E Marcin, Daniel R Calerdon, John A Faulkner.   

Abstract

Myostatin is a negative regulator of muscle mass. The impact of myostatin deficiency on the contractile properties of healthy muscles has not been determined. We hypothesized that myostatin deficiency would increase the maximum tetanic force (P(o)), but decrease the specific P(o) (sP(o)) of muscles and increase the susceptibility to contraction-induced injury. The in vitro contractile properties of extensor digitorum longus (EDL) and soleus muscles from wild-type (MSTN(+/+)), heterozygous-null (MSTN(+/-)), and homozygous-null (MSTN(-/-)) adult male mice were determined. For EDL muscles, the P(o) of both MSTN(+/-) and MSTN(-/-) mice were greater than the P(o) of MSTN(+/+) mice. For soleus muscles, the P(o) of MSTN(-/-) mice was greater than that of MSTN(+/+) mice. The sP(o) of EDL muscles of MSTN(-/-) mice was less than that of MSTN(+/+) mice. For soleus muscles, however, no difference in sP(o) was observed. Following two lengthening contractions, EDL muscles from MSTN(-/-) mice had a greater force deficit than that of MSTN(+/+) or MSTN(+/-) mice, whereas no differences were observed for the force deficits of soleus muscles. Myostatin-deficient EDL muscles had less hydroxyproline, and myostatin directly increased type I collagen mRNA expression and protein content. The difference in the response of EDL and soleus muscles to myostatin may arise from differences in the levels of a myostatin receptor, activin type IIB. Compared with the soleus, the amount of activin type IIB receptor was approximately twofold greater in EDL muscles. The results support a significant role for myostatin not only in the mass of muscles but also in the contractility and the composition of the extracellular matrix of muscles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709649      PMCID: PMC4088255          DOI: 10.1152/japplphysiol.00126.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  69 in total

1.  Effects of the compact mutant myostatin allele Mstn (Cmpt-dl1Abc) introgressed into a high growth mouse line on skeletal muscle cellularity.

Authors:  Charlotte Rehfeldt; Gerhard Ott; David E Gerrard; László Varga; Werner Schlote; John L Williams; Ulla Renne; Lutz Bünger
Journal:  J Muscle Res Cell Motil       Date:  2005-07-01       Impact factor: 2.698

2.  Myostatin propeptide-mediated amelioration of dystrophic pathophysiology.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Lisa-Anne Whittemore; Tejvir S Khurana
Journal:  FASEB J       Date:  2005-04       Impact factor: 5.191

Review 3.  Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases.

Authors:  James F Tobin; Anthony J Celeste
Journal:  Curr Opin Pharmacol       Date:  2005-06       Impact factor: 5.547

4.  Transgenic engineering of male-specific muscular hypertrophy.

Authors:  Dimitri Pirottin; Luc Grobet; Antoine Adamantidis; Frédéric Farnir; Christian Herens; Henrik Daa Schrøder; Michel Georges
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

5.  Alterations of temporalis muscle contractile force and histological content from the myostatin and Mdx deficient mouse.

Authors:  Craig D Byron; Mark W Hamrick; Christopher J Wingard
Journal:  Arch Oral Biol       Date:  2005-11-02       Impact factor: 2.633

Review 6.  Muscle regeneration through myostatin inhibition.

Authors:  Kathryn R Wagner
Journal:  Curr Opin Rheumatol       Date:  2005-11       Impact factor: 5.006

7.  Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles.

Authors:  Lucas G Prado; Irina Makarenko; Christian Andresen; Martina Krüger; Christiane A Opitz; Wolfgang A Linke
Journal:  J Gen Physiol       Date:  2005-10-17       Impact factor: 4.086

8.  Muscle regeneration in the prolonged absence of myostatin.

Authors:  Kathryn R Wagner; Xiaosong Liu; Xiaoli Chang; Ronald E Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

9.  Short-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the rat.

Authors:  A Matsakas; A Friedel; T Hertrampf; P Diel
Journal:  Acta Physiol Scand       Date:  2005-03

10.  Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice.

Authors:  Seumas McCroskery; Mark Thomas; Leanne Platt; Alex Hennebry; Takanori Nishimura; Lance McLeay; Mridula Sharma; Ravi Kambadur
Journal:  J Cell Sci       Date:  2005-08-01       Impact factor: 5.285

View more
  68 in total

1.  Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.

Authors:  Kevin J Morine; Lawrence T Bish; Joshua T Selsby; Jeffery A Gazzara; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; Se-Jin Lee; H Lee Sweeney
Journal:  Muscle Nerve       Date:  2010-11       Impact factor: 3.217

2.  Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type.

Authors:  Samuel M Cadena; Kathleen N Tomkinson; Travis E Monnell; Matthew S Spaits; Ravindra Kumar; Kathryn W Underwood; R Scott Pearsall; Jennifer L Lachey
Journal:  J Appl Physiol (1985)       Date:  2010-05-13

Review 3.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

4.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

5.  Skeletal muscle gene expression after myostatin knockout in mature mice.

Authors:  Stephen Welle; Andrew Cardillo; Michelle Zanche; Rabi Tawil
Journal:  Physiol Genomics       Date:  2009-06-09       Impact factor: 3.107

6.  Changes in skeletal muscle and tendon structure and function following genetic inactivation of myostatin in rats.

Authors:  Christopher L Mendias; Evan B Lynch; Jonathan P Gumucio; Michael D Flood; Danielle S Rittman; Douglas W Van Pelt; Stuart M Roche; Carol S Davis
Journal:  J Physiol       Date:  2015-02-25       Impact factor: 5.182

7.  Mouse forepaw lumbrical muscles are resistant to age-related declines in force production.

Authors:  Katelyn A Russell; Rainer Ng; John A Faulkner; Dennis R Claflin; Christopher L Mendias
Journal:  Exp Gerontol       Date:  2015-03-08       Impact factor: 4.032

Review 8.  Mechanisms for fiber-type specificity of skeletal muscle atrophy.

Authors:  Yichen Wang; Jeffrey E Pessin
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

9.  Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle.

Authors:  Erik P Rader; Rolf Turk; Tobias Willer; Daniel Beltrán; Kei-Ichiro Inamori; Taylor A Peterson; Jeffrey Engle; Sally Prouty; Kiichiro Matsumura; Fumiaki Saito; Mary E Anderson; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-13       Impact factor: 11.205

10.  Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.

Authors:  Tingqing Guo; William Jou; Tatyana Chanturiya; Jennifer Portas; Oksana Gavrilova; Alexandra C McPherron
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.